Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ / shares in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue
Expenses:
Cost of sales
Research and development	1,577
Selling, general and administrative	71,788	52,680
Total expenses	73,365	52,680
Loss from operations	(73,365)	(52,680)
Other income (expense)
Interest income (expense)	96
Nonoperating Income (Expense), Total	96
Net loss	$ (73,269)	$ (52,680)
Net loss per share - basic and diluted (in dollars per share)	$ 0	$ 0
Weighted-average number of common shares outstanding - basic and diluted (in shares)	67,022,568	45,572,568